Fmoc-L-beta-HSer(tBu)-OH

Fmoc-L-beta-HSer(tBu)-OH is an Fmoc-protected amino acid derivative of L-β-homoserine bearing a tert-butyl-substituted side-chain hydroxyl, placing it in the hydroxy-functional amino acid class used for peptide-related synthesis. The molecule contains an N-terminal fluorenylmethoxycarbonyl (Fmoc) protecting group on the amino functionality and a free carboxylic acid, while the side-chain hydroxyl is masked as a tert-butyl ether to control chemoselectivity during coupling and to reduce undesired side reactions. In solid-phase or solution-phase peptide synthesis workflows, this protected analogue functions as a stepwise building block for incorporating β-hydroxyserine-like residues with orthogonal protection patterns that support later deprotection and downstream derivatization.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25581

CAS No:203854-51-7

Synonyms/Alias:203854-51-7;Fmoc-O-t-butyl-L-beta-homoserine;FMOC-L-BETA-HOMOSERINE(OTBU);Fmoc-beta-Homoser(tBu)-OH;(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)butanoicacid;AmbotzFAA6740;AC1MC56Y;Fmoc-??-HoSer(tBu)-OH;FMOC-L-BETA-HOMOSERINE;03696_FLUKA;CTK8F0647;Fmoc-L-beta-Homo-Ser(OtBu)-OH;MolPort-003-794-004;ZINC2386827;Fmoc-O-tert-butyl-L-beta-homoserine;MFCD01862865;AKOS015901005;RTR-062338;AJ-35389;AK124394;AB0044734;TR-062338;FT-0697972;Z5733;I14-15620

Chemical Name:N-beta-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-homoserine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C23H27NO5
M.W/Mr.
397.46
Application
Peptide synthesis; Drug screening

Fmoc-L-beta-HSer(tBu)-OH is an Fmoc-protected L-β-homoserine derivative bearing a tert-butyl-protected side-chain hydroxyl group, providing a chiral amino acid scaffold with orthogonal functional-group masking for peptide chemistry. The molecule contains an Fmoc carbamate on the α-amino group for base-labile protection, a free carboxylic acid for C-terminal activation, and a β-hydroxyl functionality that is sterically protected as a tBu ether to control side reactions during coupling and chain elongation. The stereogenic center at the β-position in the L-configuration supports stereochemically defined peptide analogs and downstream derivatization. The combination of a protected amino acid backbone and protected side-chain alcohol positions the compound as a process-compatible intermediate for protected amino acid synthesis, peptide building block preparation, and selective functional-group unmasking.

1. Peptide Synthesis

Fmoc-L-beta-HSer(tBu)-OH is used in solid-phase peptide synthesis and related peptide building block preparation where the Fmoc group enables controlled N-terminal assembly and the free carboxylic acid supports peptide coupling chemistry. The α-amino protection as an Fmoc carbamate allows stepwise deprotection and re-coupling, while the β-hydroxyl protected as a tBu ether reduces competing acylation or side-chain participation during amide bond formation. The L-β-homoserine stereochemistry helps maintain defined spatial orientation of the side-chain hydroxyl in the resulting peptide sequence. Side-chain unmasking after chain assembly can provide a handle for further functionalization, enabling hydroxyl-bearing peptide analog construction and amino acid derivative elaboration for biochemical research.

2. Side-Chain Functionalization

Fmoc-L-beta-HSer(tBu)-OH serves as a protected side-chain functionalization intermediate for converting β-hydroxy amino acid motifs into chemically modified derivatives after selective deprotection. The tBu-protected hydroxyl can be removed under conditions compatible with peptide or fragment stability, generating a reactive alcohol for subsequent esterification, ether formation, or linkage to electrophiles used in chemical biology workflows. The β-homoserine chain length and hydroxyl position can be leveraged to tune spacing in conjugates, including linkers for biomolecule labeling and scaffold decoration. Downstream transformation of the liberated hydroxyl supports synthesis of peptidomimetics and structure-defined analogs used in SAR studies and molecular design programs, where controlled functional-group placement is critical.

3. Bioconjugation Chemistry

Fmoc-L-beta-HSer(tBu)-OH is applicable to bioconjugation strategies that require a defined hydroxyl-containing amino acid handle within peptide-based linkers or capture motifs. The protected alcohol minimizes undesired reactions during assembly of peptide conjugates, while the Fmoc-protected α-amino group supports incorporation into N-terminal or internal peptide segments that later undergo deprotection and conjugation. The resulting β-hydroxy functionality can be used for site-directed coupling chemistries that rely on alcohol reactivity, including formation of stable linkages to carbonyl-activated partners or other electrophiles in conjugate synthesis. The stereodefined L-β-homoserine backbone can help preserve conformational preferences of the linker region in biomolecule-modified constructs used for biochemical assays and applied molecular labeling.

4. Protected Amino Acid Chemistry

Fmoc-L-beta-HSer(tBu)-OH functions as a chiral protected amino acid intermediate for orthogonally protected amino acid synthesis, combining Fmoc N-protection with tBu side-chain protection. The Fmoc carbamate provides base-labile deprotection behavior that is compatible with iterative peptide coupling cycles, while the tert-butyl ether masking on the β-hydroxyl helps suppress side reactions such as intramolecular cyclization or unintended acylation. The free carboxylic acid enables formation of activated derivatives for coupling, fragment elaboration, or incorporation into longer synthetic sequences. The compound's protected-group pattern supports downstream deprotection planning, enabling selective generation of an alcohol-bearing amino acid residue for subsequent derivatization, intermediate preparation, and controlled stereochemical outcomes in peptide science.

5. Pharmaceutical Manufacturing

Fmoc-L-beta-HSer(tBu)-OH can be incorporated into manufacturing-oriented peptide intermediate routes where protected amino acids are used to control functional-group reactivity during scale-up. The Fmoc-protected amino group and masked side-chain hydroxyl reduce cross-reactivity during coupling operations, supporting reliable assembly of peptide building blocks that can later be converted to hydroxyl-functionalized products through planned deprotection steps. The stereochemically defined L-β-homoserine residue supports consistent structure formation for peptide-based intermediates used in fine chemical synthesis and specialty chemical production. The compound's role as a protected amino acid input aligns with process chemistry needs for reproducible intermediate generation and downstream transformation into defined peptide analogs used in applied research and industrial manufacturing workflows.

Size
1 g;5 g;
InChI
1S/C23H27NO5/c1-23(2,3)29-13-15(12-21(25)26)24-22(27)28-14-20-18-10-6-4-8-16(18)17-9-5-7-11-19(17)20/h4-11,15,20H,12-14H2,1-3H3,(H,24,27)(H,25,26)/t15-/m1/s1
InChI Key
SKYFRYZPXHNPOK-OAHLLOKOSA-N
Canonical SMILES
CC(C)(C)OCC(CC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Nucleic Acids SynthesisPeptide Modification ServicesEpitope Mapping ServicescGMP Peptide ServicePeptide Analysis ServicesPeptide CDMOPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers